- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-06-01-2009
Pharmaceutical Executive
Hans Bishop, Bayer Healthcare
June 01, 2009
0
0
Pharma vet Hans Bishop readily admits to being ruthless in his career.
Jennifer Spear Smith, Wyeth
June 01, 2009
0
0
Jennifer Spear Smith may be soft-spoken and petite, but she is loud, clear, and stands tall for one part of industry that she is clearly passionate about: continuing medical education (CME).
Stefan Platz, Roche
June 01, 2009
0
0
I started off as a pathologist at Boehringer-Ingelheim in Germany.
Virginia Carden Carnahan, Vertex Pharmaceuticals
June 01, 2009
0
0
I got my first taste of this industry as an intern at Schering-Plough's Managed Care group.
Jeffrey Tong, Infinity Pharmaceuticals
June 01, 2009
0
0
My first introductions to medically relevant biology and chemistry began when I worked with Harvard professor Greg Verdine to figure out how enzymes recognized and repaired damaged DNA.
Elizabeth Mutisya, Solvay Pharmaceuticals
June 01, 2009
0
0
I started my career as a medical liaison. It was a wonderful opportunity to shape how companies and physicians further scientific understanding of difficult medical problems, focus on key research questions, and address unmet patient needs.
Blair Jackson, Alkermes
June 01, 2009
0
0
When Pfizer discontinued Exubera, its disastrously unsuccessful inhaled insulin, in 2007, the soul searching wasn't limited to Manhattan's East 42nd Street.
On the Right Pathways
June 01, 2009
Columns
0
0
With staggering year-over-year growth, biosimilars are "the future of medicine." Marketers must position their companies for the inevitable changes.
Domestic Intervention
June 01, 2009
Column
0
0
The United States needs a new focus on educating its future labor force; and it needs parents to take the main role.
Craig Dashefsky, Schering-Plough
June 01, 2009
0
0
I have had the tremendous good fortune of strong leadership throughout my career.
Joe Mclane, Merck
June 01, 2009
0
0
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers.
Frank Karbe, Exelixis
June 01, 2009
0
0
Prior to joining Exelixis, I was an investment banker at Goldman Sachs, focusing on M&A and corporate finance.
Michelle Dipp, GlaxoSmithKline
June 01, 2009
0
0
It's hard to believe that Michelle Dipp has been in the industry for only five years considering her significant impact thus far on it.
High School Justice
June 01, 2009
From the Editor
0
0
FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop.
Emerging Leaders 2009: The Faces of Innovation
June 01, 2009
Features
0
0
Our second annual Emerging Leadership Awards cast the spotlight on 27 young rising stars most notable for their dedication and contribution to the pharma industry. Here's a closer look at why.
Jason Rhodes, Alnylam
June 01, 2009
0
0
I've always loved the life sciences, and have been fortunate to have my career take place during a time of profound advances in biology.
Carrolee Barlow, Braincells, Inc.
June 01, 2009
0
0
If Carrolee Barlow has her way, the next new class of antidepressants will be branded BCI for BrainCells, Inc., the hot young San Diego biopharma riding the wave of neurogenesis.
Luca Santarelli, Roche
June 01, 2009
0
0
Even in our crowd of underage overachievers, Luca Santarelli, MD, PhD, is a standout.
Pay For Play
June 01, 2009
Features
0
0
The P4P movement is here. Pharma marketers, it's time to take note.
Learning to Relate
June 01, 2009
Columns
0
0
A multi-phase implementation strategy can debunk the myth that social media won't work for pharma.
Jean-Marc Huet, Bristol-Myers Squibb
June 01, 2009
0
0
There is increasing importance of differentiation in the pharmaceutical industry, especially given the political, regulatory, and financial challenges we face.
Joe Shields, Wyeth
June 01, 2009
0
0
People define "work" differently. For some, it's making useful objects that you can see and touch.
C. Randall Mills, Osiris Therapeutics
June 01, 2009
0
0
I worked my way through college in the emergency room. It taught me a lot about life, death, and human suffering.
Scott Cormack, Oncogenex Pharmaceuticals
June 01, 2009
0
0
I began my career with an interest in medicine and pharmaceutical sciences.
Ceci Zak, Sanofi-Aventis US
June 01, 2009
0
0
The catalyst for innovation in the current environment is that people are living longer and the industry is not equipped to handle the significant burden that will place on the system.
Paulash Mohsen, Pfizer
June 01, 2009
0
0
The Primary Care Business Unit at Pfizer has taken some major steps to respond to the needs of our customers.
Julia Walker, Astrazeneca
June 01, 2009
0
0
I started out as a cardiovascular primary care sales rep with Merck in the UK.
Stephanie Bova, Pfizer
June 01, 2009
0
0
At 22, Stephanie Bova left the United States to teach English in Japan.
Don Sawyer, Astrazeneca
June 01, 2009
0
0
In 1990, Don Sawyer entered industry like many others do: as a sales representative.
A Bigger, Bolder Agency
June 01, 2009
Washington Report
0
0
FDA is seeking more resources to support compliance and oversight.
Kathryn Metcalfe, Pfizer
June 01, 2009
0
0
I trained as a journalist and worked at news organizations where all the reporters wanted to cover politics and crime.
Mohan Bangalore, Wyeth
June 01, 2009
0
0
In 1993, my father died of lung cancer in India. During the years I watched him suffer with the disease, I decided that I would join pharmaceutical industry after my PhD to develop drugs (particularly aimed at treating cancer) and help improve the lives of patients.